Literature DB >> 28213433

Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution.

Samuel F Bakhoum1,2, Dan Avi Landau2,3,4.   

Abstract

Large-scale, massively parallel sequencing of human cancer samples has revealed tremendous genetic heterogeneity within individual tumors. Indeed, tumors are composed of an admixture of diverse subpopulations-subclones-that vary in space and time. Here, we discuss a principal driver of clonal diversification in cancer known as chromosomal instability (CIN), which complements other modes of genetic diversification creating the multilayered genomic instability often seen in human cancer. Cancer cells have evolved to fine-tune chromosome missegregation rates to balance the acquisition of heterogeneity while preserving favorable genotypes, a dependence that can be exploited for a therapeutic benefit. We discuss how whole-genome doubling events accelerate clonal evolution in a subset of tumors by providing a viable path toward favorable near-triploid karyotypes and present evidence for CIN-induced clonal speciation that can overcome the dependence on truncal initiating events.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28213433      PMCID: PMC5453382          DOI: 10.1101/cshperspect.a029611

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  40 in total

Review 1.  Targeting DNA repair in cancer: current state and novel approaches.

Authors:  Apostolos Klinakis; Dimitris Karagiannis; Theodoros Rampias
Journal:  Cell Mol Life Sci       Date:  2019-10-14       Impact factor: 9.261

2.  Cyclin A2 regulates symmetrical mitotic spindle formation and centrosome amplification in human colon cancer cells.

Authors:  Jun-An Li; Bai-Chun Liu; Ying Song; Xin Chen
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Mild replication stress causes aneuploidy by deregulating microtubule dynamics in mitosis.

Authors:  Nicolas Böhly; Magdalena Kistner; Holger Bastians
Journal:  Cell Cycle       Date:  2019-08-25       Impact factor: 4.534

4.  TET1 regulates DNA repair in human glial cells.

Authors:  Katherine J Kuhns; Hernando Lopez-Bertoni; Jonathan B Coulter; Joseph P Bressler
Journal:  Toxicol Appl Pharmacol       Date:  2019-07-03       Impact factor: 4.219

5.  NEDD9 links anaplastic thyroid cancer stemness to chromosomal instability through integrated centrosome asymmetry and DNA sensing regulation.

Authors:  Henry G Yu; Krikor Bijian; Sabrina D da Silva; Jie Su; Gregoire Morand; Alan Spatz; Moulay A Alaoui-Jamali
Journal:  Oncogene       Date:  2022-04-22       Impact factor: 9.867

Review 6.  Untangling the web of intratumour heterogeneity.

Authors:  Zheqi Li; Marco Seehawer; Kornelia Polyak
Journal:  Nat Cell Biol       Date:  2022-08-08       Impact factor: 28.213

7.  Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinoma.

Authors:  Angel Chao; Chyong-Huey Lai; Tzu-Hao Wang; Shih-Ming Jung; Yun-Shien Lee; Wei-Yang Chang; Lan-Yang Yang; Fei-Chun Ku; Huei-Jean Huang; An-Shine Chao; Chin-Jung Wang; Ting-Chang Chang; Ren-Chin Wu
Journal:  J Mol Med (Berl)       Date:  2018-05-03       Impact factor: 4.599

8.  Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology.

Authors:  Renzo G DiNatale; A Ari Hakimi; Timothy A Chan
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

Review 9.  Tumour evolution in hepatocellular carcinoma.

Authors:  Amanda J Craig; Johann von Felden; Teresa Garcia-Lezana; Samantha Sarcognato; Augusto Villanueva
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-02       Impact factor: 46.802

10.  MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway.

Authors:  Junhong Guan; Changzheng Lu; Qihuang Jin; Huiming Lu; Xiang Chen; Lei Tian; Yanbin Zhang; Janice Ortega; Junqiu Zhang; Silvia Siteni; Mingyi Chen; Liya Gu; Jerry W Shay; Anthony J Davis; Zhijian J Chen; Yang-Xin Fu; Guo-Min Li
Journal:  Cancer Cell       Date:  2020-12-17       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.